Important Notices

Important notices for the whole De La Salle College community.

Education Maintenance Allowance (EMA) 2015

The Department of Education and Early Childhood Development (DEECD) has advised schools that from the commencement of 2015, the EMA has been discontinued and parents will not be able to apply for the EMA in 2015.

Immuron donates vital medication for Coolies trip

De La Salle College would like to acknowledge the donation by Immuron of their tablet Travelan for use by each of the students and staff on the 2014 Year 12 Coolies trip to India. Travelan has been proven toreduce the risk of ‘travellers’ tummy’ and the symptoms of minor gastrointestinal disorders.

Immuron Ltd is a publicly listed Australian biopharmaceutical company (ASX: IMC) focused on oral immunotherapy using dairy‐derived polyclonal antibody products for humans.Travelan® is a natural product which is specifically designed to prevent infection by ETEC, the most common cause of traveller’s tummy. It is the only effective preventative treatment on the market. Travelan is approved as a listed medicine in Australia and has been sold over‐the‐counter in selected pharmacies throughout Australia.

The TGA approved indications for Travelan are:

  • Reduces the risk of travellers’ tummy.
  • Reduces the symptoms of minor gastrointestinal disorders.

Essentially, Travelan contains the natural ingredient bovine colostrum that is harvested from Australian dairy cows immunised with a proprietary ETEC vaccine. As a result their colostrum contains high levels of antibodies against the common strains of ETEC bacteria. These antibodies bind to ETEC bacteria, blocking them from attaching to the epithelial cells in the gastrointestinal tract and thereby neutralising their ability to cause travellers’ tummy and its associated symptoms.

Travelan has undergone a number of independent double‐blinded, placebo‐controlled clinical trials in Europe and the USA. The trials showed protection of more than 90% against infection with the type of E.coli that causes traveller’s tummy. In addition, trials showed a significant reduction in abdominal cramps and stomach pain compared to those who did not receive Travelan. There were no reported side effects in the clinical trials.1

We are very grateful to Immuron for their generous support of our Coolies trip.

 

 

 

Back to The Duce Issue 2014 13 - 13 November 2014